Evidence map›Paper›PMID 32709495›Full record

GuidelineJournal of geriatric oncology2020

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.

Nicolò Matteo Luca Battisti, Anna Rachelle Mislang, Lisa Cooper, Anita O'Donovan, Riccardo A Audisio, Kwok-Leung Cheung, Regina Gironés Sarrió, Reinhard Stauder, Enrique Soto-Perez-de-Celis, Michael Jaklitsch and 13 more

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Journal of geriatric oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2023
    Article
  12. Afebrile chemotherapy-induced neutropenia: an international survey spots oncologists' routine clinical practice versus the standard of care and the impact of COVID-19.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 15 countries.

Nicolò Matteo Luca BattistiBreast Unit, Department of Medicine Department, The Royal Marsden NHS Foundation Trust, Breast Cancer Research Division, The Institute of Cancer Research, London, UK. Electronic address: nicolo.battisti@rmh.nhs.uk.
Anna Rachelle MislangDepartment of Medical Oncology, Flinders Centre for Innovation in Cancer, Bedford Park, SA, Australia. Electronic address: Anna.Mislang@sa.gov.au.
Lisa CooperDivision of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: lcooper5@bwh.harvard.edu.
Anita O'DonovanDiscipline of Radiation Therapy, Trinity College, Dublin, Ireland. Electronic address: Anita.ODonovan@tcd.ie.
Riccardo A AudisioDepartment of surgery, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: raudisio@doctors.org.uk.
Kwok-Leung CheungSchool of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, UK. Electronic address: kl.cheung@nottingham.ac.uk.
Regina Gironés SarrióDepartment of Medical Oncology, Hospital Universitari i Politècnic La FE, Valencia, Spain.
Reinhard StauderDepartment of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck, Austria. Electronic address: reinhard.stauder@i-med.ac.at.
Enrique Soto-Perez-de-CelisDepartment of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: enrique.sotop@incmnsz.mx.
Michael JaklitschBrigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: mjaklitsch@bwh.harvard.edu.
Grant R WilliamsInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA. Electronic address: grwilliams@uabmc.edu.
Shane O'HanlonUniversity College Dublin, St Vincent's University Hospital, Dublin, Ireland. Electronic address: shaneohanlon@svhg.ie.
Mahmood AlamPfizer Oncology, Asia Pacific Region, Australia. Electronic address: Mahmood.Alam2@pfizer.com.
Clarito CairoNational Integrated Cancer Control Program, Department of Health, Manila, Philippines.
Giuseppe CollocaPoliclinico A. Gemelli, Rome, Italy.
Luiz Antonio GilGeriatric Division, São Paulo University, São Paulo, Brazil.
Schroder SattarCollege of Nursing, University of Saskatchewan, Regina, Canada. Electronic address: schroder.sattar@usask.ca.
Kumud KantilalSchool of Pharmacy, University of East Anglia, Norwich, UK. Electronic address: k.kantilal@uea.ac.uk.
Chiara RussoDepartment of Medical Oncology, Centre Léon Bérard, Regional Comprehensive Cancer Centre, Claude-Bernard Lyon-1 University, Lyon, France. Electronic address: Chiara.RUSSO@lyon.unicancer.fr.
Stuart M LichtmanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: LichtmaS@mskcc.org.
Etienne BrainDepartment of Medical Oncology, Institut Curie/Saint-Cloud, Paris, France. Electronic address: Etienne.brain@curie.fr.
Ravindran KanesvaranDepartment of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: ravindran.kanesvaran@singhealth.com.sg.
Hans WildiersDepartment of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: hans.wildiers@uzleuven.be.
Harvard University · USAgostino Gemelli University Polyclinic · ITCentre Léon Bérard · FRDepartment of Health · PHFlinders Medical Centre · AUHospital Universitari i Politècnic La Fe · ESInnsbruck Medical University · ATInstitut Curie · FRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXKU Leuven · BEMemorial Sloan Kettering Cancer Center · USNational Cancer Centre Singapore · SGPfizer (Australia) · AURoyal Derby Hospital · GBRoyal Marsden NHS Foundation Trust · GBTrinity College Dublin · IEUniversidade de São Paulo · BRUniversity College Dublin · IEUniversity of Alabama at Birmingham · USUniversity of East Anglia · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M StudyK08CA234225 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, GRANT R · 2018 to 2022
$1.0M
NCI NIH HHS K08 CA234225NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The COVID-19 pandemic poses a barrier to equal and evidence-based management of cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel of experts to develop consensus recommendations on the implications of the pandemic on several aspects of cancer care in this age group including geriatric assessment (GA), surgery, radiotherapy, systemic treatment, palliative care and research. Age and cancer diagnosis are significant predictors of adverse outcomes of the COVID-19 infection. In this setting, GA is particularly valuable to drive decision-making. GA may aid estimating physiologic reserve and adaptive capability, assessing risk-benefits of either providing or temporarily withholding treatments, and determining patient preferences to help inform treatment decisions. In a resource-constrained setting, geriatric screening tools may be administered remotely to identify patients requiring comprehensive GA. Tele-health is also crucial to ensure adequate continuity of care and minimize the risk of infection exposure. In general, therapeutic decisions should favor the most effective and least invasive approach with the lowest risk of adverse outcomes. In selected cases, this might require deferring or omitting surgery, radiotherapy or systemic treatments especially where benefits are marginal and alternative safe therapeutic options are available. Ongoing research is necessary to expand knowledge of the management of cancer in older adults. However, the pandemic presents a significant barrier and efforts should be made to ensure equitable access to clinical trials and prospective data collection to elucidate the outcomes of COVID-19 in this population.

Indexed as

Geriatric AssessmentAgedConsensusCOVID-19GeriatricsHumansMedical OncologyNeoplasmsPalliative CarePandemicsRisk AssessmentSocieties, MedicalCompeting risksCOVID-19Geriatric oncologyOlder patientsRecommendationsSARS-CoV-2

Identifiers

PMID32709495
PMCPMC7365054
OpenAlexW3042859035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.